Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Active & Responsive
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
for
Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: Female
Age: 18+
Code: NCT07655934
Recruiting
Active & Responsive
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
for
Bone Pain, Metastatic Malignant Neoplasm in the Bone,
Location: Philadelphia PA, New York NY, Boston MA, Atlanta GA,
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03858205
Recruiting
Active & Responsive
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: Philadelphia PA, Lebanon NH, Columbus OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04165798
Recruiting
Active & Responsive
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
for
Pancreatic Adenocarcinoma Metastatic
Location: Philadelphia PA, Boston MA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06747845
Phase 2, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Philadelphia PA, East Brunswick NJ, Lancaster PA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Philadelphia PA, Baltimore MD, Pittsburgh PA, Durham NC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Philadelphia PA, Cary NC, Wilmington NC, Warrenville IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase 1, Phase 2, Recruiting
Active & Responsive
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
for
Fibrodysplasia Ossificans Progressiva
Location: Philadelphia PA, Toronto, Edmonton, San Francisco CA
Sponsor: Ipsen
Sex: All
Age: 8+
Code: NCT06089616
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Philadelphia PA, White Plains NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE)
Location: Philadelphia PA
Sponsor: Victoria Werth
Sex: All
Age: 18+
Code: NCT07694336
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Media PA, Brooklyn NY, New York NY, Washington D.C. DC,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
for
Amyotrophic Lateral Sclerosis
Location: Philadelphia PA, Baltimore MD, Worcester MA,
Sponsor: Insmed Gene Therapy LLC
Sex: All
Age: 18 - 70+
Code: NCT07290062
Phase 1, Recruiting
Active & Responsive
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
for
Glioblastoma Multiforme
Location: Philadelphia PA
Sponsor: Global Neurosciences Institute
Sex: All
Age: 18+
Code: NCT02285959
Phase 1, Recruiting
Active & Responsive
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder
Location: Philadelphia PA, Wilmington DE, West Haven CT,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04375033
Recruiting
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT04038502
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for
Anemia, Sickle Cell, Healthy Volunteers
Location: Philadelphia PA, New Haven CT, Fairfax VA, Richmond VA,